Stock SYMBA SYMBOLLON PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Symbollon Pharmaceuticals Inc. Stock

Equities

SYMBA

US87151H1068

Biotechnology & Medical Research

Delayed OTC Bulletin Board
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Symbollon Pharmaceuticals Inc. -.--% -.--%

Chart Symbollon Pharmaceuticals Inc.

Dynamic Chart

Managers and Directors - Symbollon Pharmaceuticals Inc.

Managers TitleAgeSince
Jack H. Kessler FOU
 Founder 72 86-06-30
Paul C. Desjourdy CEO
 Chief Executive Officer 61 93-08-31
Members of the board TitleAgeSince
Paul C. Desjourdy CEO
 Chief Executive Officer 61 93-08-31
Jack H. Kessler FOU
 Founder 72 86-06-30
Eugene Lieberstein BRD
 Director/Board Member 84 97-12-31
More insiders

Company Profile

More about the company

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+11.91% 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+11.60% 106B
BIONTECH SE Stock BioNTech SE
-4.68% 24.28B
ARGENX SE Stock argenx SE
-0.82% 21.96B
GENMAB A/S Stock Genmab A/S
-10.12% 18.16B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-42.12% 16.37B
BEIGENE, LTD. Stock BeiGene, Ltd.
-17.47% 15.56B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+2.77% 13.63B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+34.58% 12.27B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. SYMBA Stock